Viewing Study NCT04781634


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2025-12-28 @ 7:38 PM
Study NCT ID: NCT04781634
Status: RECRUITING
Last Update Posted: 2025-02-25
First Post: 2021-02-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory B-ALL
Sponsor: Chongqing Precision Biotech Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module